Raphael Pharmaceutical (RAPH) Enterprise Value (2020 - 2025)
Raphael Pharmaceutical (RAPH) posted Enterprise Value of -$45000.0 for Q4 2025, down 1400.0% sequentially from -$3000.0 in Q3 2025, and down 136.84% YoY from $122142.9 in Q4 2024.
Raphael Pharmaceutical (RAPH) Enterprise Value (2020 - 2025) Analysis & Trends
Raphael Pharmaceutical has reported Enterprise Value for 6 years, with the latest figure at -$45000.0 in Q4 2025.
- Quarterly Enterprise Value fell 136.84% year-over-year to -$45000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$45000.0 (down 136.84% YoY) and the FY2025 annual result came in at -$45000.0, down 136.84% from the prior year.
- Enterprise Value retreated to -$45000.0 in Q4 2025 per RAPH's latest filing, from -$3000.0 in the prior quarter.
- Over five years, Enterprise Value peaked at -$3000.0 in Q3 2025 and troughed at -$299000.0 in Q3 2023.
- A 5-year average of -$113833.3 and a median of -$87000.0 in 2022 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value sank 655.26% in 2024, then soared 92.5% in 2025.
- Over 5 years, Enterprise Value stood at -$153000.0 in 2021, then plunged by 88.24% to -$288000.0 in 2022, then increased by 20.14% to -$230000.0 in 2023, then jumped by 91.74% to -$19000.0 in 2024, then plunged by 136.84% to -$45000.0 in 2025.
- According to Business Quant data, Enterprise Value over the past three periods registered -$45000.0, -$3000.0, and -$20000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - | -1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -45,000.00 |
| Sep 30, 2025 | -3,000.00 |
| Jun 30, 2025 | -20,000.00 |
| Mar 31, 2025 | -50,000.00 |
| Dec 31, 2024 | -19,000.00 |
| Sep 30, 2024 | -40,000.00 |
| Jun 30, 2024 | -120,000.00 |
| Mar 31, 2024 | -287,000.00 |
| Dec 31, 2023 | -230,000.00 |
| Sep 30, 2023 | -299,000.00 |
| Jun 30, 2023 | -111,000.00 |
| Mar 31, 2023 | -38,000.00 |
| Dec 31, 2022 | -288,000.00 |
| Sep 30, 2022 | -93,000.00 |
| Jun 30, 2022 | -135,000.00 |
| Mar 31, 2022 | -81,000.00 |
| Dec 31, 2021 | -153,000.00 |
| Sep 30, 2021 | -37,000.00 |
| Dec 31, 2020 | -95,000.00 |